Valuation Dermapharm Holding SE

Stocks

Real-time Estimate Tradegate 05:45:14 2026-10-23 EDT			5-day change	1st Jan Change
38.42 ^EUR	-0.71%		+1.59%	-2.29%

09-03	Dermapharm Holding SE : Jefferies remains Neutral	ZD
08-27	Dermapharm Holding SE : Receives a Buy rating from Berenberg	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,808	2,020	2,280	2,094	2,119	1,917	-	-
Change	-	-57.98%	12.85%	-8.12%	1.16%	-9.51%	-	-
Enterprise Value (EV) ¹	5,206	2,388	3,216	2,964	2,974	2,729	2,604	2,495
Change	-	-54.13%	34.69%	-7.85%	0.33%	-8.23%	-4.58%	-4.2%
P/E	23x	15.1x	36.5x	18.4x	16x	14.8x	13x	11.7x
PBR	9.67x	3.8x	4.23x	3.47x	3.05x	2.88x	2.52x	2.21x
PEG	-	-0.4x	-0.7x	0.2x	1x	2.24x	1x	1.1x
Capitalization / Revenue	5.1x	1.97x	2.01x	1.77x	1.82x	1.59x	1.53x	1.48x
EV / Revenue	5.52x	2.33x	2.83x	2.51x	2.55x	2.26x	2.08x	1.92x
EV / EBITDA	14.8x	6.64x	10.4x	9.39x	9.16x	8x	7.19x	6.54x
EV / EBIT	17.4x	9.8x	17.6x	13.7x	13.5x	10.9x	9.74x	8.72x
EV / FCF	27.5x	9.57x	18.1x	18.2x	15.9x	17.8x	15x	13.4x
FCF Yield	3.63%	10.4%	5.53%	5.5%	6.29%	5.62%	6.66%	7.49%
Dividend per Share ²	2.17	1.05	0.88	0.9	0.88	1.02	1.139	1.217
Rate of return	2.43%	2.8%	2.08%	2.31%	2.24%	2.64%	2.94%	3.15%
EPS ²	3.89	2.49	1.16	2.11	2.46	2.623	2.967	3.296
Distribution rate	55.8%	42.2%	75.9%	42.7%	35.8%	38.9%	38.4%	36.9%
Net sales ¹	942.9	1,025	1,135	1,181	1,165	1,209	1,254	1,299
EBITDA ¹	351.1	359.8	310.2	315.6	324.8	340.9	362	381.2
EBIT ¹	298.5	243.7	182.9	216.9	220.7	249.3	267.3	286
Net income ¹	209.6	134.2	62.37	113.8	132.4	137.3	155.3	171.7
Net Debt ¹	398.1	367.8	936.6	869.4	855.1	811.7	686.9	577.5
Reference price ²	89.30	37.52	42.34	38.90	39.35	38.70	38.70	38.70
Nbr of stocks (in thousands)	53,840	53,840	53,840	53,840	53,840	49,541	-	-
Announcement Date	4/12/22	3/28/23	3/28/24	3/27/25	3/30/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
DERMAPHARM HOLDING SE	14.75x	2.26x	8x	2.64%	2.15B
ELI LILLY AND COMPANY	37.7x	13.43x	28.51x	0.52%	1,165B
JOHNSON & JOHNSON	39.17x	6.59x	18.54x	1.99%	645B
ABBVIE INC.	36.4x	8.37x	17.27x	2.41%	504B
ROCHE HOLDING AG	20.97x	5.15x	12.78x	2.55%	380B
MERCK & CO., INC.	107.33x	5.99x	25.72x	2.31%	363B
NOVARTIS AG	21.95x	5.71x	14.04x	2.79%	297B
ASTRAZENECA PLC	22.67x	4.58x	13.09x	1.93%	269B
AMGEN INC.	28.38x	7.14x	12.79x	2.26%	237B
GILEAD SCIENCES, INC.	-45.82x	7.02x	27.23x	2.1%	195B
Average	28.35x	6.62x	17.80x	2.15%	405.76B
Weighted average by Cap.	35.72x	8.44x	20.73x	1.78%